SAFETY, TOLERABILITY, AND PHARMACOKINETICS ATER SINGLE AND MULTIPLE DOSES OF MK-5172, A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS, IN HEALTHY SUBJECTS
HEPATOLOGY（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined